hydroxyurea has been researched along with Tauopathies in 2 studies
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giannopoulos, PF | 2 |
Chiu, J | 1 |
Praticò, D | 2 |
Chu, J | 1 |
Sperow, M | 1 |
Li, JG | 1 |
Yu, WH | 1 |
Kirby, LG | 1 |
Abood, M | 1 |
2 other studies available for hydroxyurea and Tauopathies
Article | Year |
---|---|
Learning Impairments, Memory Deficits, and Neuropathology in Aged Tau Transgenic Mice Are Dependent on Leukotrienes Biosynthesis: Role of the cdk5 Kinase Pathway.
Topics: Animals; Behavior, Animal; Brain; Cyclin-Dependent Kinase 5; Hydroxyurea; Leukotriene Antagonists; L | 2019 |
Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain; Cerebellum; Cerebral Cortex; Cyclin-Dependent Kinase 5; | 2015 |